期刊名：Livers

期刊主页：https://www.mdpi.com/journal/livers

本期精选Livers期刊 2024–2025 年度 Title Story 优质文章，聚焦前沿研究热点。希望这些重磅论文能为您的科研与临床工作开拓新思路、提供核心参考。诚邀免费阅览，携手助力肝病学领域科研与临床事业高质量发展。

1. The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma

乙型肝炎病毒 PreS1/HBsAg 比值是肝细胞癌发生的预测标志物

http://www.mdpi.com/2673-4389/4/3/26

Kosaka, M.; Fujino, H.; Tsuge, M.; Uchikawa, S.; Ono, A.; Murakami, E.; Kawaoka, T.; Miki, D.; Hayes, C.N.; Oka, S. The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma. Livers 2024, 4, 364-376. https://doi.org/10.3390/livers4030026

2. A Novel Bile Duct-Saving Portal Ligation Technique for Subtotal Hepatectomy Survival Operations in Rats

一种新型的保留胆管的门静脉结扎技术在大鼠次全肝切除术后存活手术中的应用

http://www.mdpi.com/2673-4389/4/4/37

Savsani, K.; Alfonso, A.; Jo, E.; Park, A.; Lee, S.D. A Novel Bile Duct-Saving Portal Ligation Technique for Subtotal Hepatectomy Survival Operations in Rats. Livers 2024, 4, 521-533. https://doi.org/10.3390/livers4040037

3. Key Epigenetic Players in Etiology and Novel Combinatorial Therapies for Treatment of Hepatocellular Carcinoma

肝细胞癌病因学中的关键表观遗传学因素及新型联合疗法

http://www.mdpi.com/2673-4389/4/4/44

Belizário, J.; Garay-Malpartida, M. Key Epigenetic Players in Etiology and Novel Combinatorial Therapies for Treatment of Hepatocellular Carcinoma. Livers 2024, 4, 638-655. https://doi.org/10.3390/livers4040044

4. Comparison of Differentially Expressed Genes in Human Versus in Chimeric Mouse Livers Following HBV Infection

乙肝病毒感染后人肝与嵌合小鼠肝中差异表达基因的比较

http://www.mdpi.com/2673-4389/5/2/18

Bao, H.; Tsuge, M.; Murakami, S.; Fujii, Y.; Uchikawa, S.; Fujino, H.; Ono, A.; Murakami, E.; Kawaoka, T.; Miki, D.; et al. Comparison of Differentially Expressed Genes in Human Versus in Chimeric Mouse Livers Following HBV Infection. Livers 2025, 5, 18. https://doi.org/10.3390/livers5020018

5. From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life

从“MAFLD”到“MASLD”：这场变革值得吗？MAFLD和MASLD标准在真实世界中评估肝病进展和心血管风险的直接比较

http://www.mdpi.com/2673-4389/5/4/58

Dallio, M.; Romeo, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Basile, C.; Coppola, A.; Silvestrin, A.; Senese, G.; Niosi, M.; et al. From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life. Livers 2025, 5, 58. https://doi.org/10.3390/livers5040058

6. Gender Differences in Healthy Eating Index as Informed by the Awareness of Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease

根据对代谢功能障碍相关脂肪肝疾病诊断的认知程度，探讨健康饮食指数的性别差异

http://www.mdpi.com/2673-4389/5/4/61

Lin, W.-T.; Novack, M.; Liangpunsakul, S.; Huang, C.-K.; Lin, H.-Y.; Chen, P.-H.; Tseng, T.-S.; Ting, P.-S. Gender Differences in Healthy Eating Index as Informed by the Awareness of Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Livers 2025, 5, 61. https://doi.org/10.3390/livers5040061

7. The Epidemiology of Chronic Hepatitis C: Where We Are Now

慢性丙型肝炎的流行病学：我们现在所处的位置

http://www.mdpi.com/2673-4389/4/2/13

Stasi, C.; Milli, C.; Voller, F.; Silvestri, C. The Epidemiology of Chronic Hepatitis C: Where We Are Now. Livers 2024, 4, 172-181. https://doi.org/10.3390/livers4020013

8. The Hepatokine Leukocyte Cell-Derived Chemotaxin-2 Is Elevated in People with Impaired Glycaemic Regulation and Augmented by Acute Exercise

肝细胞衍生趋化因子2在血糖调节受损人群中水平升高，且急性运动可增强其水平

http://www.mdpi.com/2673-4389/4/1/5

Engin, B.; Willis, S.A.; Malaikah, S.; Sargeant, J.A.; Stensel, D.J.; Jelleyman, C.; Ennequin, G.; Aithal, G.P.; Yates, T.; King, J.A. The Hepatokine Leukocyte Cell-Derived Chemotaxin-2 Is Elevated in People with Impaired Glycaemic Regulation and Augmented by Acute Exercise. Livers 2024, 4, 51-62. https://doi.org/10.3390/livers4010005

9. Cutaneous Manifestations of Liver Cirrhosis: Clinical Significance and Diagnostic Implications

肝硬化的皮肤表现：临床意义和诊断价值

http://www.mdpi.com/2673-4389/5/3/37

Kamoua, R.; Reese, R.; Annamraju, R.; Chen, T.; Doyle, C.; Parella, A.; Liu, A.; Abboud, Y.; Rohan, C.; Travers, J.B. Cutaneous Manifestations of Liver Cirrhosis: Clinical Significance and Diagnostic Implications. Livers 2025, 5, 37. https://doi.org/10.3390/livers5030037

期刊主题涵盖肝炎 所有形式；酒精性肝病；非酒精性脂肪性肝病和非酒精性脂性肝炎；肝硬化；胆道疾病；药物性肝损伤；遗传性和代谢性肝病及其并发症；癌症与药物代谢；肝细胞癌；肝纤维化；肝病免疫学；肝病学营养；肝病病理学；肝病的诊断和治疗，为肝病学多学科领域的基础、转化和高级临床研究提供平台。目前已被 ESCI（Web of Science）、Scopus 等国际权威数据库收录。